Skip to main navigation Skip to search Skip to main content

A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/16/16 → 05/15/22

Funding

  • TG Therapeutics Incorporated: $26,006.25